Communication subscriptions and data use purpose for product-level consent
Key Takeaway
To manage consent per product, create a Data Use Purpose that links the Life Sciences Marketable Product, then select it on the Communication Subscription. The Communication Subscription Channel Type defines how the healthcare professional is contacted. It doesn't define which product the consent covers.
In Life Sciences Cloud for Customer Engagement, healthcare professionals use the Consent page to choose which communication topics they agree to receive. Each topic is a Communication Subscription record. You can link the subscription to a Data Use Purpose that points to a Life Sciences Marketable Product. With that link, you manage and organize consent for specific products instead of for communication in general.
Three records split the work
A Communication Subscription record adds a new subscription topic to the Consent page in the Life Sciences Cloud for Customer Engagement app. Healthcare professionals choose from these topics. Two other records connect to the subscription, and each of the three records answers a different question.
| Record | Question it answers |
|---|---|
| Communication Subscription | What does the healthcare professional subscribe to? |
| Data Use Purpose | Which product does it concern? |
| Communication Subscription Channel Type | How is the healthcare professional contacted? |
The Data Use Purpose is the object that makes consent product-level, because it associates a Life Sciences Marketable Product with a Communication Subscription.
A Communication Subscription Channel Type record associates a subscription with an engagement channel type, such as email, SMS, or direct mail. A healthcare professional can select that channel type as their primary mode of communication. So the channel type sets the contact method, and the Data Use Purpose sets the product.
A company markets two products, Cardiovex and Dermalin. The admin creates one Data Use Purpose for each product. Next, the admin creates a Communication Subscription called "Cardiovex updates" and selects the Cardiovex data use purpose. A second subscription, "Dermalin updates", uses the Dermalin data use purpose. Both subscriptions offer email as a channel type. Dr. Lee opens the Consent page, subscribes to "Cardiovex updates", and leaves "Dermalin updates" unchecked. Her consent is tied to Cardiovex, not to email in general. Email is only how the company reaches her about Cardiovex.